Amanote Research

Amanote Research

    RegisterSign In

The Costs of Drug Prescriptions for Diabetes in the NHS

The Lancet - United Kingdom
doi 10.1016/s0140-6736(18)33190-8
Full Text
Open PDF
Abstract

Available in full text

Categories
Medicine
Date

January 1, 2019

Authors
Mike StedmanMark LuntMark LivingstonAnthony A FryerGabriela MorenoSusan BaileyRoger GadsbyAdrian Heald
Publisher

Elsevier BV


Related search

Serious Drug-Drug Interactions in the Prescriptions of Diabetic Patients

Medical Sciences
2015English

The Impact of Diabetes on Prescription Drug Costs: The Population-Based Turin Study

Diabetologia
Internal MedicineEndocrinologyMetabolismDiabetes
2008English

Study on the Prescriptions of Drug Interactions in Hospitalized Patients.

Japanese Journal of Hospital Pharmacy
1995English

Modernising the NHS: Leading the Way With Diabetes

The Lancet
Medicine
2019English

We Must Recognise the Actual and Opportunity Costs of Treating Immigrants in the NHS

Journal of the Royal Society of Medicine
Medicine
2014English

Drug Costs: The Controversy Continues

Journal of Pain and Palliative Care Pharmacotherapy
AnesthesiologyPain MedicinePharmacology
2017English

Opportunity Costs of Implementing Nice Decisions in NHS Wales

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2014English

Opportunity Costs of Implementing Nice Decisions in NHS Wales

SSRN Electronic Journal
2014English

The Costs of Australian Drug Policy

Journal of Drug Issues
Mental HealthPublic HealthPsychiatryEnvironmentalHealthMedicineOccupational Health
1992English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy